Safety
dizziness, cancer, somnolence
CANCER, EDEMA PERIPHERAL
Our results indicate that mirogabalin is well tolerated in patients with cancer during chemotherapy. Most ADRs in the present study were mild or moderate, and predominantly somnolence, oedema peripheral, and dizziness. These ADRs are similar to those reported for previous studies of mirogabalin and pregabalin [